Full 20value 20scenario 20v4 1
Biozhena logo 20150heightx61width

bioZhena Corporation

Women’s health electronic diagnostic technology (SaaS) platform introduced via FDA-cleared fertility monitor, ready-to-launch

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Fort Collins, CO, USA
  • Currency USD
  • Incorporation Type C-corp
  • Website biozhena.com

Company Summary

Women’s reproductive self-care in the Information Age
FDA-cleared first application means early revenues, profitability
Transformational technology platform will empower women & enable physicians to better manage women's healthcare from adolescence to menopause
The first app helps women to either conceive or avoid pregnancy without drugs or surgery, manage stress effects
See slides w. links https://v.gd/7lC5bz
Business Plan-cum-PPM on request

Team

  • Default avatar
    Vaclav Kirsner
    Founder CEO

    Founding CEO of bioZhena Corporation, as the developer of tissue-biosensing of folliculogenesis in vivo. He was a Senior Research Scientist at the pharmaceutical firm of WRL of Glaxo Wellcome (UK), specialized in exploratory research and interdisciplinary applications. He earned his PhD in physical chemistry-electrochemistry from the University of Southampton, UK and his Masters degree from Charles University in Prague. Pls email to schedule call

Advisors

  • Default avatar
    C.R. Miles, Intellectual Property, Patent & Trademark Law
    Lawyer
    Unconfirmed

Previous Investors